A Yagoda

791 total citations
24 papers, 604 citations indexed

About

A Yagoda is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, A Yagoda has authored 24 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in A Yagoda's work include Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (5 papers) and Cancer Treatment and Pharmacology (4 papers). A Yagoda is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (5 papers) and Cancer Treatment and Pharmacology (4 papers). A Yagoda collaborates with scholars based in United States and Germany. A Yagoda's co-authors include Daniel P. Petrylak, Robert Golbey, David Braun, Nancy E. Kemeny, Edgar Cheng, Peter P. Sordillo, Joseph Brenner, Young Cw, Gordon B. Magill and Willet F. Whitmore and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Oncology.

In The Last Decade

A Yagoda

24 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Yagoda United States	11	336	259	216	197	155	24	604
K Miwa Japan	18	426 1.3×	285 1.1×	178 0.8×	276 1.4×	164 1.1×	44	866
U. Fink Germany	13	435 1.3×	402 1.6×	137 0.6×	405 2.1×	106 0.7×	26	901
Per Flodgren Sweden	13	298 0.9×	169 0.7×	265 1.2×	259 1.3×	101 0.7×	24	688
Andrzej Szawłowski Poland	8	266 0.8×	602 2.3×	211 1.0×	171 0.9×	226 1.5×	21	836
Manabu Yamamoto Japan	11	253 0.8×	237 0.9×	160 0.7×	117 0.6×	97 0.6×	26	556
E. Corgna Italy	13	275 0.8×	415 1.6×	194 0.9×	227 1.2×	67 0.4×	27	730
Anwar Tarabichi Germany	14	224 0.7×	401 1.5×	148 0.7×	196 1.0×	201 1.3×	19	786
C. Blajman Argentina	9	425 1.3×	446 1.7×	186 0.9×	180 0.9×	94 0.6×	15	759
Antonio Jirillo Italy	15	307 0.9×	595 2.3×	137 0.6×	424 2.2×	206 1.3×	60	1.1k
L Portalone Italy	11	427 1.3×	418 1.6×	156 0.7×	73 0.4×	84 0.5×	26	668

Countries citing papers authored by A Yagoda

Since Specialization

Citations

This map shows the geographic impact of A Yagoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Yagoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Yagoda more than expected).

Fields of papers citing papers by A Yagoda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Yagoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Yagoda. The network helps show where A Yagoda may publish in the future.

Co-authorship network of co-authors of A Yagoda

This figure shows the co-authorship network connecting the top 25 collaborators of A Yagoda. A scholar is included among the top collaborators of A Yagoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Yagoda. A Yagoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yagoda, A, et al.. (1995). Chemotherapy for advanced renal-cell carcinoma: 1983-1993.. PubMed. 22(1). 42–60. 304 indexed citations

Petrylak, Daniel P., et al.. (1995). PRECLINICAL STUDIES OF GOSSYPOL IN PROSTATE CARCINOMA. International Journal of Oncology. 6(1). 209–13. 6 indexed citations

Yagoda, A. (1990). Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.. PubMed. 350. 227–41. 10 indexed citations

Yagoda, A. (1989). The role of cisplatin-based chemotherapy in advanced urothelial tract cancer.. PubMed. 16(4 Suppl 6). 98–104. 7 indexed citations

Bosl, George J., Nancy L. Geller, Dean F. Bajorin, et al.. (1989). A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors. The Journal of Urology. 141(6). 1499–1500. 1 indexed citations

Sternberg, Cora N., et al.. (1988). Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.. PubMed. 277. 45–51. 2 indexed citations

Scher, Howard I., William R. Fair, A Yagoda, et al.. (1987). Clinical Downstaging After Neo-Adjuvant M-VAC for Transitional Cell Carcinoma of the Urothelium. The Journal of Urology. 137(6). 2 indexed citations

At, van Oosterom, Hideyuki Akaza, R R Hall, et al.. (1986). Response criteria phase II/phase III invasive bladder cancer.. PubMed. 221. 301–10. 19 indexed citations

Yagoda, A, et al.. (1986). Phase II trial of N-methylformamide for advanced renal cell carcinoma.. PubMed. 70(5). 681–2. 12 indexed citations

10.

Yagoda, A, et al.. (1985). Phase II trial of 10-deazaaminopterin for advanced hypernephroma.. PubMed. 4(6). 409–10. 6 indexed citations

11.

Yagoda, A, et al.. (1985). Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.. PubMed. 5(4). 415–7. 9 indexed citations

12.

Chun, Honggu, A Yagoda, Nancy Kemeny, & Robin C. Watson. (1983). Cisplatin for adrenal cortical carcinoma.. PubMed. 67(5). 513–4. 13 indexed citations

13.

Cheng, Edgar, et al.. (1983). Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.. PubMed. 67(5). 509–10. 8 indexed citations

14.

Brenner, Joseph, Gordon B. Magill, Peter P. Sordillo, Edgar Cheng, & A Yagoda. (1982). Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma. Cancer. 50(10). 2031–2033. 23 indexed citations

15.

Zeffren, J., et al.. (1981). Phase II trial of methyl-GAG in advanced renal cancer.. PubMed. 65(5-6). 525–7. 14 indexed citations

16.

Kemeny, Nancy E., A Yagoda, David Braun, & Robert Golbey. (1980). Therapy for metastatic colorectal carcinoma with a combination of methyl-CCNU, 5-fluorouracil vincristine and streptozotocin (MOF-strep). Cancer. 45(5). 876–881. 37 indexed citations

17.

Yagoda, A. (1980). Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.. PubMed. 63(9-10). 1565–72. 44 indexed citations

18.

Kemeny, Nancy E., A Yagoda, David Braun, & Robert Golbey. (1979). A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma. Cancer. 43(1). 78–82. 20 indexed citations

19.

Yagoda, A, et al.. (1977). Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.. PubMed. 61(9). 1727–9. 19 indexed citations

20.

Whitmore, Willet F., et al.. (1977). Chemotherapy of Seminoma. Recent results in cancer research. 244–249. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact